New Hampshire HB701 - Terminal Patients' Right to Try Act

New Hampshire House Bill 701 establishes the Terminal Patients' Right to Try Act, creating legal pathways for terminally ill patients to access experimental treatments, including regenerative therapies, that have not yet received full FDA approval.

Legislative Purpose

This act recognizes the fundamental right of terminal patients to make informed decisions about their medical care, including access to experimental treatments that may offer hope when conventional options have been exhausted.

Key Provisions

• Legal protection for physicians providing experimental treatments
• Patient eligibility criteria for accessing experimental therapies
• Informed consent requirements and documentation standards
• Insurance and liability protections for healthcare providers